FDA Clearance Tracker · K232699
Low Ejection Fraction AI-ECG Algorithm
Last checked: Nov 20, 2026Latest source record: Sep 28, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Sep 28, 2023
Substantially Equivalent
Time to decision
23 days
Received Sep 5, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K232699
- Device name
- Low Ejection Fraction AI-ECG Algorithm
- Applicant
- Anumana, Inc.
- Applicant location
- Cambridge, MA
- Received
- Sep 5, 2023
- Decided
- Sep 28, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.2380
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QYE (Reduced Ejection Fraction Machine Learning-Based Notification Software).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for K232699
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Anumana, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- WatchMate Software510(k)
K260300 · Decided Jun 15, 2026 · 136 days after receipt
Device type: Automated Radiological Image Processing Software (QIH) · Radiology & Imaging
- ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040)Breakthrough510(k)
K253801 · Decided Apr 7, 2026 · 130 days after receipt
Device type: Cardiac Amyloidosis Machine Learning-Based Notification Software (SHP) · Cardiology
- ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm (1020)Breakthrough510(k)
K252360 · Decided Mar 28, 2026 · 242 days after receipt
Device type: Pulmonary Hypertension Machine Learning-Based Notification Software (SAT) · Cardiology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.